中国学者近期发表的论文
1.	Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China. Author: Chen XZ1. Journal: JAMA Oncol. 2019 Jan 1;5(1):116-117. doi: 10.1001/jamaoncol.2018.5526.    PubMed      DOI
2.	Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Author: McCaw ZR1, Jiang F2, Wei LJ1. Journal: JAMA Oncol. 2019 Jan 1;5(1):117-118. doi: 10.1001/jamaoncol.2018.5730.    PubMed      DOI
3.	Risk of Diabetes Associated With Cancer Development. Author: Hu D1, Peng F2, Niu W3. Journal: JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6619. [Epub ahead of print]    PubMed      DOI
4.	First-line Nivolumab Plus Ipilimumab vs Sunitinib for Metastatic Renal Cell Carcinoma: A Cost-effectiveness Analysis. Author: Wan X1,2, Zhang Y1,2, Tan C1,2, Zeng X3, Peng L1,2. Journal: JAMA Oncol. 2019 Feb 21. doi: 10.1001/jamaoncol.2018.7086. [Epub ahead of print]    PubMed      DOI
5.	Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer. Author: Liu B1, Dong K1, Dong R1. Journal: JAMA Oncol. 2019 Feb 21. doi: 10.1001/jamaoncol.2018.7217. [Epub ahead of print]    PubMed      DOI
6.	Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults. Author: Yang W1,2, Ma Y2,3, Liu Y2,4, Smith-Warner SA5,6, Simon TG7,8,9, Chong DQ10, Qi Q11, Meyerhardt JA12, Giovannucci EL2,5,6, Chan AT2,8,9, Zhang X2. Journal: JAMA Oncol. 2019 Feb 21. doi: 10.1001/jamaoncol.2018.7159. [Epub ahead of print]    PubMed      DOI
7.	Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel. Author: Wang Z1, Duan J1, Cai S2, Han M3, Dong H3, Zhao J4, Zhu B5, Wang S6, Zhuo M4, Sun J5, Wang Q7, Bai H1, Han J1, Tian Y1, Lu J3, Xu T2, Zhao X2, Wang G2, Cao X3, Li F3, Wang D8, Chen Y8, Bai Y2, Zhao J2, Zhao Z2, Zhang Y2, Xiong L2, He J1, Gao S1, Wang J1. Journal: JAMA Oncol. 2019 Feb 28. doi: 10.1001/jamaoncol.2018.7098. [Epub ahead of print]    PubMed      DOI
8.	Tumor Mutation Load and Frequently Mutated Genes in Gastric Cancer-In Reply. Author: Li X1, Zhang W2, Chen K3. Journal: JAMA Oncol. 2019 Mar 7. doi: 10.1001/jamaoncol.2019.0135. [Epub ahead of print]    PubMed      DOI
9.	Widespread Thickened, Verrucous, Hyperpigmented Plaques in a Woman With Weight Loss. Author: Yuan C1,2, Liu L1,2, Wang M1,2. Journal: JAMA Oncol. 2019 Mar 14. doi: 10.1001/jamaoncol.2018.7153. [Epub ahead of print]    PubMed      DOI
10.	Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care. Author: Haider A1, Qian Y2, Lu Z1, Naqvi S1, Zhuang A1, Reddy A1, Dalal S1, Arthur J1, Tanco K1, Dev R1, Williams J1, Wu J3, Liu D3, Bruera E1. Journal: JAMA Oncol. 2019 Mar 21. doi: 10.1001/jamaoncol.2019.0062. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore CA-A CANCER JOURNAL FOR CLINICIANS 144 160.19 NEW ENGLAND JOURNAL OF MEDICINE 933 16.10 NATURE REVIEWS DRUG DISCOVERY 289 9.90 LANCET 700 10.28 Nature Reviews Clinical Oncology 127 8.04 NATURE REVIEWS CANCER 396 23.23 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 622 6.98 Nature Reviews Disease Primers 48 25.88 World Psychiatry 61 6.95 World Psychiatry 70 8.13

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 300060 CANCER RESEARCH 165884 Molecular Medicine Reports 164664 International Journal of Nanomedicine 164432 CANCER LETTERS 159477 JOURNAL OF ETHNOPHARMACOLOGY 141676 BIOMEDICINE & PHARMACOTHERAPY 140567 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 135930 Theranostics 135909 International Journal of Environmental Research and Public Health 133597